News + Filings Transactions
|
Huang Jane
| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 10/04/2023 | Prelude Therapeutics Inc | PRLD | Exercise | Restricted Stock Unit | 9.4k | $0.00 | $0 | | 10/04/2023 |
| 07/04/2023 | Prelude Therapeutics Inc | PRLD | Payment of Exercise | Common Stock | 3.2k | $4.65 | $15.1k | | 07/04/2023 |
| 07/04/2023 | Prelude Therapeutics Inc | PRLD | Exercise | Restricted Stock Unit | 9.4k | $0.00 | $0 | | 07/04/2023 |
| 06/07/2023 | Protara Therapeutics, Inc. | PRTO | Grant | Stock Option (Right to Buy) | 10k | $2.85 | $28.5k | | 06/07/2023 |
| 02/07/2023 | Prelude Therapeutics Inc | PRLD | Grant | Employee Stock Option (right to buy) | 150k | $7.20 | $1.1M | | 02/07/2023 |
| 06/08/2022 | Protara Therapeutics, Inc. | PRTO | Grant | Stock Option (Right to Buy) | 10k | $3.50 | $35k | | 06/08/2022 |
| 05/02/2022 | Prelude Therapeutics Inc | PRLD | Grant | Employee Stock Option (Right to Buy) | 460k | $4.86 | $2.2M | | 05/02/2022 |
| 05/02/2022 | Prelude Therapeutics Inc | PRLD | Grant | Restricted Stock Unit | 150k | $0.00 | $0 | | 05/02/2022 |
| 12/14/2021 | BeiGene, Ltd. | BGNE | Exercise | | 1.5k | $119.96 | $179.9k | | 12/14/2021 |
| 12/14/2021 | BeiGene, Ltd. | BGNE | Sale | | 300 | $274.54 | $82.4k | | 12/14/2021 |
| 12/14/2021 | BeiGene, Ltd. | BGNE | Sale | | 300 | $276.95 | $83.1k | | 12/14/2021 |
| 12/14/2021 | BeiGene, Ltd. | BGNE | Sale | | 500 | $278.21 | $139.1k | | 12/14/2021 |
| 12/14/2021 | BeiGene, Ltd. | BGNE | Sale | | 100 | $278.79 | $27.9k | | 12/14/2021 |
| 12/14/2021 | BeiGene, Ltd. | BGNE | Sale | | 200 | $281.64 | $56.3k | | 12/14/2021 |
| 12/14/2021 | BeiGene, Ltd. | BGNE | Sale | | 100 | $284.52 | $28.5k | | 12/14/2021 |
| 12/14/2021 | BeiGene, Ltd. | BGNE | Exercise | Share Option (Right to Buy) | 19.5k | $0.00 | $0 | | 12/14/2021 |
| 12/01/2021 | BeiGene, Ltd. | BGNE | Sale | | 519 | $362.45 | $188.1k | | 11/30/2021 |
| 12/01/2021 | BeiGene, Ltd. | BGNE | Sale | | 530 | $357.32 | $189.4k | | 11/30/2021 |
| 11/30/2021 | BeiGene, Ltd. | BGNE | Grant | Ordinary Shares | 14.8k | $0.00 | $0 | | 11/30/2021 |
| 11/30/2021 | BeiGene, Ltd. | BGNE | Grant | | 1k | $0.00 | $0 | | 11/30/2021 |
| 11/17/2021 | BeiGene, Ltd. | BGNE | Sale | | 100 | $377.92 | $37.8k | | 11/17/2021 |
| 11/17/2021 | BeiGene, Ltd. | BGNE | Sale | | 100 | $384.16 | $38.4k | | 11/17/2021 |
| 11/17/2021 | BeiGene, Ltd. | BGNE | Sale | | 100 | $385.28 | $38.5k | | 11/17/2021 |
| 11/17/2021 | BeiGene, Ltd. | BGNE | Sale | | 300 | $387.94 | $116.4k | | 11/17/2021 |
| 11/17/2021 | BeiGene, Ltd. | BGNE | Exercise | Share Option (Right to Buy) | 19.5k | $0.00 | $0 | | 11/17/2021 |
| 11/17/2021 | BeiGene, Ltd. | BGNE | Sale | | 100 | $379.88 | $38k | | 11/17/2021 |
| 11/17/2021 | BeiGene, Ltd. | BGNE | Sale | | 200 | $381.41 | $76.3k | | 11/17/2021 |
| 11/17/2021 | BeiGene, Ltd. | BGNE | Sale | | 100 | $382.42 | $38.2k | | 11/17/2021 |
| 11/17/2021 | BeiGene, Ltd. | BGNE | Exercise | | 1.5k | $119.96 | $179.9k | | 11/17/2021 |
| 11/17/2021 | BeiGene, Ltd. | BGNE | Sale | | 200 | $376.16 | $75.2k | | 11/17/2021 |
| 11/17/2021 | BeiGene, Ltd. | BGNE | Sale | | 300 | $377.14 | $113.1k | | 11/17/2021 |
| 10/19/2021 | BeiGene, Ltd. | BGNE | Sale | | 100 | $377.71 | $37.8k | | 10/19/2021 |
| 10/19/2021 | BeiGene, Ltd. | BGNE | Exercise | Share Option (Right to Buy) | 19.5k | $0.00 | $0 | | 10/19/2021 |
| 10/19/2021 | BeiGene, Ltd. | BGNE | Exercise | | 1.5k | $119.96 | $179.9k | | 10/19/2021 |
| 10/19/2021 | BeiGene, Ltd. | BGNE | Sale | | 200 | $362.05 | $72.4k | | 10/19/2021 |
|
|